Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France

Journal of Neuro-Oncology

Volumn 120, Issue 3, 2014, Pages 547-555

  Darlix, Amélie ^a,b   Zouaoui, Sonia ^a,b,c   Virion, Jean Marc ^d   Rigau, Valérie ^c   Mathieu Daudé, Hélène ^a   Blonski, Marie ^d   Reyes Botero, German ^e   Bessaoud, Faiza ^a   Trétarre, Brigitte ^a   Bauchet, Fabienne ^a   Capelle, Laurent ^e   Fabbro, Michel ^a   Kerr, Christine ^a   Figarella Branger, Dominique ^f   Duffau, Hugues ^b,c   Taillandier, Luc ^g   Bauchet, Luc ^b,c  

^a CENTRE VAL D AURELLE   (France)

^b Montpellier University Medical Center   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f University of the Mediterranean Aix Marseille II   (France)

^g POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Brain tumor; Epidemiology; Glioma; Neurooncology

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; EUROPE; FEMALE; FRANCE; GENETIC HETEROGENEITY; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; GLIOMA; HEREDITY; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; POPULATION DENSITY; POPULATION DISTRIBUTION; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE; UNITED STATES; AGE; BRAIN NEOPLASMS; GENETIC DATABASE; INCIDENCE; MIDDLE AGED; NEWBORN; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DATABASES, GENETIC; FEMALE; FRANCE; GLIOMA; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SEX FACTORS; YOUNG ADULT;

EID: 84911423404     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1585-0     Document Type: Article

References (36)

1. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109
2. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14(suppl 5):v1–v49
3. Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93–108
4. Wöhrer A, Waldhör T, Heinzl H et al (2009) The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol 95:401–411
5. Baldi I, Gruber A, Alioum A et al (2011) Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. Neuro Oncol 13:1370–1378
6. Ron E, Modan B, Boice JD, Alfandary E, Stovall M, Katz L (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319:1033–1039
7. Yonehara S, Brenner AV, Kishikawa M et al (2004) Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995. Cancer 101:1644–1654
8. Bondy ML, Scheurer ME, Malmer B et al (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113(7 Suppl):1953–1968
9. McCarthy BJ, Rankin KM, Aldape K et al (2011) Risk factors for oligodendroglial tumors: a pooled international study. Neuro Oncol 13:242–250
10. Crocetti E, Trama A, Stiller C et al (2012) Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer 48:1532–1542
11. Houben MP, Coebergh JW, Birch JM, Tijssen CC, van Duijn CM, McNally RJ (2005) Space–time clustering patterns of gliomas in the Netherlands suggest an infectious aetiology. Eur J Cancer 41:2917–2923
12. Houben MP, Coebergh JW, Birch JM, Tijssen CC, van Duijn CM, McNally RJ (2006) Space-time clustering of glioma cannot be attributed to specific histological subgroups. Eur J Epidemiol 21:197–201
13. Bauchet L, Rigau V, Mathieu-Daudé H et al (2007) French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol 84:189–199
14. Bauchet L, Rigau V, Mathieu-Daudé H et al (2009) Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol 92:87–98
15. Bauchet L, Mathieu-Daudé H, Fabbro-Peray P et al (2010) Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol 12:725–735
16. Rigau V, Zouaoui S, Mathieu-Daudé H et al (2012) French brain tumor database: 5- year histological results on 25756 cases. Brain Pathol 21:633–644
17. Zouaoui S, Rigau V, Mathieu-Daudé H et al (2012) French brain tumor database: general results on 40,000 cases, main current applications and future prospects. Neurochirurgie 58:4–13
18. Hartmann C, von Deimling A (2009) Molecular pathology of oligodendroglial tumors. Recent Results Cancer Res 171:25–49
19. van den Bent MJ (2010) Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective. Acta Neuropathol 120(3):297–304
20. Davis FG, Malmer BS, Aldape K et al (2008) Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 17(3):484–489
21. Okamoto Y, Di Patre P-L, Burkhard C, Horstmann S, Jourde B, Fahey M et al (2004) Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 108:49–56
22. Arora RS, Alston RD, Eden TO et al (2010) Are reported increases in incidence of primary CNS tumours real ? An analysis of longitudinal trends in England, 1979-2003. Eur J Cancer 46:1607–1616
23. Chan DS, Lau R, Aune D et al (2011) Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 6(6):e20456
24. Aleksandrova K, Nimptsch K, Pischon T (2013) Influence of obesity and related metabolic alterations on colorectal cancer risk. Curr Nutr Rep 2(1):1–9
25. Boeing H, Schlehofer B, Blettner M, Wahrendorf J (1993) Dietary carcinogens and the risk for glioma and meningioma in Germany. Int J Cancer 53(4):561–565
26. Blowers L, Preston-Martin S, Mack WJ (1997) Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA). Cancer Causes Control 8:5–12
27. Kyritsis AP, Bondy ML, Levin VA (2011) Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents. Nutr Cancer 63(2):174–184
28. Huncharek M, Kupelnick B, Wheeler L (2003) Dietary cured meat and the risk of adult glioma: a meta-analysis of nine observational studies. J Environ Pathol Toxicol Oncol 22(2):129–137
29. Michaud DS, Holick CN, Batchelor TT, Giovannucci E, Hunter DJ (2009) Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma. Am J Clin Nutr 90:570–577
30. Dubrow R, Daresky AS, Park Y et al (2010) Dietary components related to N-Nitroso compound formation: a prospective study of adult glioma. Cancer Epidemiol Biomarkers Prev 19(7):1709–1722
31. Fromont A, Binquet C, Sauleau EA et al (2010) Geographic variations of multiple sclerosis in France. Brain 133:1889–1899
32. Fromont A, Binquet C, Sauleau E et al (2012) National estimate of multiple sclerosis incidence in France (2001-2007). Mult Scler 18(8):1108–1115
33. Vukusic S, Van Bockstael V, Gosselin S, Confavreux C (2006) Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry 78:707–709
34. Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7(3):268–277
35. Kampman MT, Wilsgaard T, Mellgren SI (2007) Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 254(4):471–477
36. Mohr SB, Gorham ED, Garland CF, Grant WB, Garland FC (2010) Low ultraviolet B and increased risk of brain cancer: an ecological study of 175 countries. Neuroepidemiology 35(4):281–290